(Total Views: 640)
Posted On: 04/13/2019 9:02:00 AM
Post# of 30067
Re: jamesfranklin #27703
We licensed it and then dropped the ball in developing it.
Psychogenics sued us and we settled giving them 40% of Elto Pharma. Chan owns 10% too. We own the other 50%.
AMBS, psychogenics and Chan are selling elto to Coeptis for 7.5 million shares of Coeptis upfront and a possible additional 7.5 million sharesupon hitting predefined milestones.
We (AMBS) get either 3.75 million or 7.5 million of those shares of Coeptis (depending on whether milestones are hit).
Psychogenics sued us and we settled giving them 40% of Elto Pharma. Chan owns 10% too. We own the other 50%.
AMBS, psychogenics and Chan are selling elto to Coeptis for 7.5 million shares of Coeptis upfront and a possible additional 7.5 million sharesupon hitting predefined milestones.
We (AMBS) get either 3.75 million or 7.5 million of those shares of Coeptis (depending on whether milestones are hit).
(4)
(0)
